I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is ..:
Guja, Cristian
;
Kis, Janos Tibor
;
Haluzik, Martin
...
https://discovery.ucl.ac.uk/id/eprint/10168810/2/Freemantle_iGlarLixi_AOP.pdf. , 2023
Link:
https://discovery.ucl.ac.uk/id/eprint/10168810/2/Freem..
RT Journal T1
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data
UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10168810&Exemplar=1&LAN=DE A1 Guja, Cristian A1 Kis, Janos Tibor A1 Haluzik, Martin A1 Bonnemaire, Mireille A1 Bigot, Gregory A1 Tournay, Mathilde A1 Freemantle, Nick A1 Seufert, Jochen PB WILEY YR 2023 K1 Science & Technology K1 Life Sciences & Biomedicine K1 Endocrinology & Metabolism K1 age K1 elderly K1 fixed-ratio combination K1 iGlarLixi K1 insulin glargine K1 lixisenatide K1 real-world data K1 type 2 diabetes K1 LIXILAN JF https://discovery.ucl.ac.uk/id/eprint/10168810/2/Freemantle_iGlarLixi_AOP.pdf LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10168810/2/Freemantle_iGlarLixi_AOP.pdf DO https://discovery.ucl.ac.uk/id/eprint/10168810/2/Freemantle_iGlarLixi_AOP.pdf SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)